North Carolina Pharmacists' Support for Hormonal Contraception Prescription Status Change.


Journal

Journal of pharmacy practice
ISSN: 1531-1937
Titre abrégé: J Pharm Pract
Pays: United States
ID NLM: 8900945

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 17 7 2023
pubmed: 25 3 2022
entrez: 24 3 2022
Statut: ppublish

Résumé

BackgroundPharmacist-prescribed hormonal contraception (HC) may offer additional avenues of access for patients; however, it is unknown whether pharmacists would support over-the-counter access to contraception over pharmacist-prescribed models.

Identifiants

pubmed: 35325584
doi: 10.1177/08971900221074966
pmc: PMC10350693
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-776

Références

Contraception. 2008 Jan;77(1):1-5
pubmed: 18082659
Contracept X. 2021 Jul 30;3:100069
pubmed: 34430846
Pharmacy (Basel). 2020 Oct 16;8(4):
pubmed: 33081094
Obstet Gynecol. 2019 Jun;133(6):1238-1246
pubmed: 31135740
Contraception. 2015 May;91(5):373-9
pubmed: 25732570
J Rural Health. 2022 Jun;38(3):639-649
pubmed: 34355426
J Pharm Pract. 2021 Apr;34(2):230-238
pubmed: 31390938
Contraception. 2013 Jul;88(1):91-6
pubmed: 23352799
J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):521-6
pubmed: 27594105
Contraception. 2013 Oct;88(4):544-52
pubmed: 23664627
J Womens Health (Larchmt). 2016 Mar;25(3):249-54
pubmed: 26666711
Contraception. 2006 Dec;74(6):463-70
pubmed: 17157103
Obstet Gynecol. 2019 Oct;134(4):e96-e105
pubmed: 31568364
N Engl J Med. 2016 Mar 3;374(9):843-52
pubmed: 26962904
Obstet Gynecol. 2015 Jan;125(1):250-255
pubmed: 25560140
Obstet Gynecol. 2019 Jun;133(6):1231-1237
pubmed: 31135739
J Am Pharm Assoc (2003). 2019 Sep - Oct;59(5):633-641
pubmed: 31300307
Womens Health Issues. 2016 Mar-Apr;26(2):153-60
pubmed: 26549241
Contraception. 2004 Jul;70(1):31-9
pubmed: 15208050
Perspect Sex Reprod Health. 2014 Jun;46(2):83-9
pubmed: 24602230
JAMA Netw Open. 2020 May 1;3(5):e205252
pubmed: 32432710
Womens Health Issues. 2012 May-Jun;22(3):e311-8
pubmed: 22555219
J Pharm Pract. 2019 Feb;32(1):54-61
pubmed: 29096570

Auteurs

Rachel A Parry (RA)

Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Gwen Seamon (G)

Mountain Community Health Partnership, Burnsville, NC, USA.

Mollie Ashe Scott (MA)

UNC Health Sciences, Mountain Area Health Education Center, Asheville, NC, USA.
Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Casey R Tak (CR)

Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH